Table 1 Demographics and Patient RCC Characteristics
Characteristics | Patients N = 21 |
|---|---|
Age, median years (range) | 56.0 (22-68) |
Sex, n (%) | |
Male | 16 (76) |
Female | 5 (24) |
Race, n (%) | |
Caucasian | 19 (91) |
Black | 1 (5) |
Asian | 1 (5) |
Time from diagnosis to 1 st sunitinib dose, mean weeks (SD) | 10.8 (6.41) |
ECOG performance status, n (%) | |
0 | 15 (71) |
1 | 6 (29) |
MSKCC risk [ 23 ], n (%) | |
Favorable (0 risk factors) | 0 |
Intermediate (1-2 risk factors) | 15 (71) |
Poor (≥3 risk factors) | 6 (29) |
Heng risk [ 24 ], n (%) | |
Favorable (0 risk factors) | 0 |
Intermediate (1-2 risk factors) | 11 (52) |
Poor (≥3 risk factors) | 10 (48) |
Fuhrman nuclear grade, n (%) | |
Grade 2 | 5 (24) |
Grade 3 | 9 (43) |
Grade 4 | 7 (33) |
Tumor Size, n (%) | |
TX | 2 (10) |
T1 | 3 (14) |
T2 | 1 (5) |
T3 | 13 (62) |
T4 | 2 (10) |
Regional Lymph Nodes Staging, n (%) | |
NX | 10 (48) |
N0 | 6 (29) |
N1 | 1 (5) |
N2 | 4 (19) |
Distant Metastasis Staging, n (%) | |
M1 | 21 (100) |